Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media
More topics under "C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media" (918,689)
C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
C12N 11 - Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof (12,439)
C12N 13 - Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves (3,958)
C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
C12N 3 - Spore-forming or isolating processes (415)
C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
12/2003
12/25/2003WO2003106641A2 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
12/25/2003US20030236631 Comparative field analysis (CoMFA) utilizing topomeric alignment of molecular fragments
12/25/2003US20030235533 A nucleic acid sequence that is expressed by human prostate cancer cells, an expressed antigen that elicits antibodies, diagnostic kit comprising a monoclonal antibody is used to detect prostate cancer
12/24/2003WO2003106652A2 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
12/24/2003WO2003106635A2 Functional sites
12/24/2003WO2003106631A2 Methods and compositions relating to labeled rna molecules that reduce gene expression
12/24/2003WO2003106630A2 Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
12/24/2003WO2003106614A2 Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one gelling agent and methods of using the same
12/24/2003CA2489346A1 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
12/18/2003WO2003104467A1 Means and methods for the production of adenovirus vectors
12/18/2003WO2003104431A2 Transgenic mammals expressing polyglutamine
12/18/2003WO2003104398A2 Allelic variation in human gene expression
12/18/2003WO2003104392A2 Improved reagents and methods for producing parvoviruses
12/18/2003US20030232415 Comprises nucleotide sequences coding protein associated with avermectin biosynthesis (AVEC); antibiotic preparation; veterinary medicine
12/18/2003US20030232358 Identifying the genetic factors responsible for cell differentiation based on expression cloning
12/18/2003US20030232351 Methods for analyzing methylated CpG islands and GC rich regions
12/18/2003US20030232030 Compositions containing at least one oil structured with at least one silicone-polyamide polymer, and at least one gelling agent and methods of using the same
12/18/2003CA2488932A1 Transgenic mammals expressing polyglutamine
12/17/2003CN1131314C Recombination eukaryotic carrier containing sensitinogen gene and application thereof
12/17/2003CN1131309C IL-6 mutein
12/11/2003WO2003102159A2 Novel proteins and nucleic acids encoding same
12/11/2003WO2003102155A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003WO2003102144A2 Compositions and methods of use for an ephrin rreceptor
12/11/2003WO2003102132A2 Non-affinity purification of proteins
12/11/2003WO2003064624A3 Molecular hepatotoxicology modeling
12/11/2003WO2003040324A3 Methods for mutating genes in cells and animals using insertional mutagenesis
12/11/2003WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods
12/11/2003WO2000070054A9 Pathogen-resistant grape plants
12/11/2003WO1999024553A3 X-ray crystal comprising hiv-1 gp120
12/11/2003US20030229910 Preparing transgenic cattle which are resistant to bovine spongioform encephalopathy; homologous recombination; animal husbandry; veterinary medicine
12/11/2003US20030229212 Using high-performance tangential-flow filtration (HPTFF) to isolate preferential polypeptides such as immunoadhesins; high throughput assay
12/11/2003US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228618 Screening sample of nucleotide sequences for naturally occuring oligonucleotide associated with gene expression inhibition and modulation; drug screening; genetic mapping; tumor diagnosis
12/11/2003US20030228614 Measuring levels of metabolites 3-OH-3-methylindolenine, 3-methyloxindole, indole-3-carbinol, and 2-aminoacetophenone in a pig may be useful in identifying the pig's ability to metabolize skatole and its susceptibility to boar taint
12/11/2003CA2478925A1 Non-affinity purification of proteins
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP0502892B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
12/10/2003CN1461338A Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
12/09/2003US6660843 Fusion of Fc domains with biologically active peptides
12/04/2003WO2003100044A1 New improved acyltransferase
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003100032A2 Dwarfism genes and dwarf plants
12/04/2003WO2003100028A2 Tr2, tr4, tr2/tr4 double knockouts and uses thereof
12/04/2003WO2003100013A2 NON-REVERTIBLE β-OXIDATION BLOCKED CANDIDA TROPICALIS
12/04/2003WO2003100002A2 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
12/04/2003WO2003099998A2 Gene expression profiling of adult soft tissue sarcoma
12/04/2003WO2003099196A2 Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency
12/04/2003WO2003078570A9 Multiple controls for molecular genetic analyses
12/04/2003WO2003072747A8 COMPARATIVE MOLECULAR FIELD ANALYSIS (CoMFA) UTILIZING TOPOMERIC ALIGNMENT OF MOLECULAR FRAGMENTS
12/04/2003WO2003050267A3 Method of isolating extract from the euphorbaciae obesa plant and methods for using the same
12/04/2003WO2003050264A3 Method for the analysis of differential gene expression
12/04/2003WO2003048338A3 Nucleic acid injected into hepatic vein lumen and delivered to primate liver
12/04/2003WO2003048329A3 Chromosomal saturation mutagenesis
12/04/2003WO2003006625A3 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
12/04/2003WO2003001876A3 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/04/2003US20030226177 Dwarfism genes and dwarf plants
12/04/2003US20030226154 Pathophysiology associated with a single gene (MASS 1) mutation underlying the robust audiogenic seizure phenotype in frings mice
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224458 Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidney
12/04/2003US20030224450 Comprises nucleotide sequences coding transient receptor potential channel (TRP) for use in diagnosis and treatment of osteoporosis, nervous system, kidney and cancer disorders
12/04/2003US20030224383 Atherosclerotic phenotype determinative genes and methods for using the same
12/04/2003US20030224353 Uncharged oligomers having a targeting base sequence that is substantially complementary to a viral target sequence which spans the AUG start site of the first open reading frame of the viral genome
12/04/2003CA2487006A1 Predicting the significance of single nucleotide polymorphisms (snps) using ensemble-based structural energetics
12/04/2003CA2478833A1 Anti-.alpha.v.beta.6 antibodies
12/03/2003EP1366769A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing extracellular matrix receptor-ligand interaction
12/03/2003CN1129796C Medicine box for detecting hepatitis virus C and use thereof
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/27/2003WO2003097812A2 Transgenic ungulates capable of human antibody production
11/27/2003WO2003097805A2 Delivery of nucleic acid-like compounds
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003027262A3 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003US20030219768 Lung cancer therapeutics and diagnostics
11/27/2003US20030219764 Using mathematical models associated with mutational analysis to observe, determine and detect genes associated with preferential metabolic pathways
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003US20030219420 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells
11/27/2003CA2752143A1 Delivery of nucleic acid-like compounds
11/27/2003CA2484655A1 Transgenic ungulates capable of human antibody production
11/20/2003WO2003095624A2 Liver inflammation predictive genes
11/20/2003WO2003095620A2 Oocyte recording chamber
11/20/2003WO2003095608A2 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/20/2003WO2003035842A3 Hybridization control of sequence variation
11/20/2003US20030216288 Methods and compositions for treating aids and HIV-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules
11/20/2003US20030215782 Frozen spermatozoa compositions and uses thereof
11/20/2003US20030215542 Reduction of cystine containing polypeptides such as gliadins, glutenins, albumin or globulins, using thioredoxin or transferase enzymes; deactivation of neurotoxins
11/20/2003US20030215457 Comprising a nucleic acid, a polypeptide encoded by the nucleic acid, and a compound, preferably an antibody or fragment thereof, that binds to the polypeptide, preferably binding to the extracellular domain of LIV-1 polypeptide
11/20/2003US20030215448 Compositions and methods for treating hyperimmune response in the eye
11/20/2003CA2484549A1 Liver inflammation predictive genes
11/20/2003CA2460679A1 Dna microarrays comprising active chromatin elements and comprehensive profiling therewith
11/19/2003EP0665890B1 Increased production of secreted proteins by recombinant eukaryotic cells
11/18/2003US6649347 Use of methylated nucleic acid segments for isolating centromere DNA
11/13/2003WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003WO2003033673A3 High-throughput transcriptome and functional validation analysis
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003022215A3 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
11/13/2003US20030211597 Genetically engineered hepatitis C viral (HVC) particle for use in prevention, diagnosis and prognostication of viral infections; immunoassays; genetic vaccines diagnosis
11/13/2003US20030211477 Carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) structure and uses thereof in drug identification and screening
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 100